News|Articles|January 2, 2018

Risk Assessments and Sourcing Strategies for Excipients and APIs

Author(s)USP

External Link - PT1217 USP-Andruski F&C pr1f2-Web.pdf

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!

Related Content

Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production

BySusan Haigney

January 23rd 2026

M4Q(R2) Draft Guidance | Created with Canva

FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use

ByChristopher Cole

January 23rd 2026

USP Digital Quality Standard | Created with Canva

USP Develops Digital Quality Standards for Global Pharmaceutical Manufacturing

ByZachary Zubulake

January 22nd 2026

Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs

ByChristopher Cole

January 22nd 2026

Ask the Expert: Collaboration Ensures Effective Procurement

BySusan J. Schniepp,Siegfried Schmitt

January 22nd 2026

Risk Assessments and Sourcing Strategies for Excipients and APIs

Newsletter

Related Content

Integrating AI Discovery, Continuous Manufacturing, and Modern Regulatory Hurdles into Pharma Production

FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use

USP Develops Digital Quality Standards for Global Pharmaceutical Manufacturing

Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs

Ask the Expert: Collaboration Ensures Effective Procurement

Trending on Pharmaceutical Technology

Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs

West Launches New Prefillable Syringe System that Streamlines Biologic Delivery

The Shift from Containment to Protection: Packaging Trends Impacting Pharma

State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment

Ask the Expert: Collaboration Ensures Effective Procurement